Placeholder

Metoprolol Succinate

  • # LGM Pharma is a Metoprolol Succinate CAS# 98418-47-4 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Metoprolol Succinate
  • CAS #: 98418-47-4
  • IUPAC: 2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, butanedioate (2:1) (salt)
  • ATC: C07AB02
  • PubChem: 4171
  • DrugBank: APRD00208
  • Formula: C15-H25-N-O3.1/2C4-H6-O4
  • Molecular Mass: 652.82
  • Synonyms: (+-)-1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol succinate (2:1) (salt), 2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, butanedioate (2:1) (salt), Beloc- Zok, H 93/26 succinate, Metoprolol succinate, Metoprolol succinate extended-release tablets, Seloken ZOC, Selozok, Spesicor Dos, Toprol, Toprol XL, Toprol-XL, UNII-TH25PD4CCB
  • SMILES: c1(ccc(cc1)CCOC)OC[C@@H](CNC(C)C)O.C(CC(O)=O)C(O)=O.c1(ccc(CCOC)cc1)OC[C@@H](CNC(C)C)O
  • InChl: 1S/2C15H25NO3.C4H6O4/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-3(6)1-2-4(7)8/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2H2,(H,5,6)(H,7,8)
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants

 

  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements
This website uses cookies. By using our site, you agree to our terms of service